Rigel Pharmaceuticals | RIGL - Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.48M 509K 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Celldex Therapeutics USD 28.87M 7.17M 2025-12
Daiichi Sankyo JPY 542.16B 97.68B 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Neurocrine Biosciences USD 713M 372.8M 2025-12
Pfizer USD 1.34B 295M 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Veracyte USD 362.58M 47M 2025-12